Pan-T Booster Co-expressing MSLN CAR T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pan-T Booster Co-expressing MSLN CAR T Cell Therapy, covering 2024-05-10 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]